Glioblastoma (GBM) is a lethal primary brain tumor characterized by treatment resistance and inevitable tumor recurrence, both of which are driven by a subpopulation of GBM cancer stem-like cells (GSC) with tumorigenic and selfrenewal properties. Despite having broad implications for understanding GSC phenotype, the determinants of upregulated DNA damage response (DDR) and subsequent radiation resistance in GSC are unknown and represent a significant barrier to developing effective GBM treatments. In this study, we show that constitutive DDR activation and radiation resistance are driven by high levels of DNA replication stress (RS). CD133+ GSC exhibited reduced DNA replication velocity and a higher frequency of stalled replication forks than CD133-non-GSC in vitro; immunofluorescence studies confirmed these observations in a panel of orthotopic xenografts and human GBM specimens. Exposure of non-GSC to low-level exogenous RS generated radiation resistance in vitro, confirming RS as a novel determinant of radiation resistance in tumor cells. GSC exhibited DNA double strand breaks (DSB) which co-localized with 'replication factories' and RNA: DNA hybrids. GSC also demonstrated increased expression of long neural genes (>1Mbp) containing common fragile sites, supporting the hypothesis that replication/transcription collisions are the likely cause of RS in GSC. Targeting RS by combined inhibition of ATR and PARP (CAiPi) provided GSCspecific cytotoxicity and complete abrogation of GSC radiation resistance in vitro.
Introduction
Despite detailed characterization of the genomic and molecular landscape of glioblastoma (GBM) life expectancy for patients with this aggressive tumor remains extremely poor (1, 2) . Standard of care comprises neurosurgical resection followed by treatment with radiotherapy and temozolomide, both of which are DNA damaging agents (3) . Accumulating evidence suggests that the inevitable recurrence of GBM after chemoradiation is driven largely by GBM cancer stem-like cells (GSC), which drive resistance to DNA damaging therapies through constitutive up regulation of the DNA damage response (DDR) (4) (5) (6) . This DDR phenotype has also been reported in cancer stem cells derived from other tumor types (7, 8) and in murine embryonic stem cells (9) . Despite a decade of research, however, the underlying cause of DDR up regulation in GSC remains unclear. While an association with elevated levels of reactive oxygen species (ROS) has been reported (10) , other studies have attributed radiation resistance to reduced levels of ROS in cancer stem cells (11) .
A consistent feature of the GSC and cancer stem cell DDR phenotype is the up regulation and/or constitutive activation of multiple components of both the DNA repair and cell cycle checkpoint pathways (4, 12) . Previously, we demonstrated the therapeutic relevance of this phenotype by showing that inhibition of both DNA repair and cell cycle checkpoint function was required to overcome radioresistance (12).
While several other reports have confirmed the radiosensitizing potential of DDR inhibition at the pre-clinical level (10, 13) progression to the clinic has been frustratingly slow. The aim of this study was to elucidate the mechanisms underlying constitutive DDR activation in GSC and use this knowledge to identify new therapeutic strategies for this cancer of unmet need. Our approach was informed by previous studies describing elevated levels of DNA replication stress (RS) in glioma specimens, particularly GBM (14) , and by emerging evidence that RS can activate a broader spectrum of DDR proteins than previously thought (15) . RS can be defined as inefficient DNA replication that causes replication forks to progress slowly or stall, and may be caused by a wide variety of cellular and environmental factors (16, 17) .
Because replication stress can have adverse consequences including permanent DNA damage and genomic instability, it evokes a spectrum of cellular responses that act to stabilize stalled forks and reduce the risk of fork collapse and consequent DNA damage. Extensive overlap between the cellular responses to RS and radiation induced DNA damage supports the hypothesis that constitutive RS might be responsible for radiation resistance.
A further question is whether GSC arise from neural progenitor cells, or are the product of de-differentiation of malignant glioma cells (18) . Embedded within this controversy is the related question of whether neural progenitor cells are the cell of origin of GBM (19) . The recently published observation that neural progenitor cells are prone to acquisition of DNA double strand breaks (DSB) at specific chromosomal sites as a consequence of RS induced by transcription of long neural genes (20) strengthens the rationale for exploring RS in GSC with a view to exploring a potential phenotypic link between these two cell populations.
In this study, we demonstrate that GSC exhibit constitutively elevated RS both in vitro and in vivo, and that S phase GSC exhibit increased levels of DSB which arise at DNA 'replication factories'. We show that exposure to exogenous RS generates significant radiation resistance in relatively radiosensitive non-GSC glioma cells. We provide evidence to support the hypothesis that RS and consequent activation of the DDR is associated with marked overexpression of very long genes, of which the most profoundly up regulated are the long neural genes previously shown to harbor DSB in neural stem cells (20) . Finally, we show that targeting the RS response through combined ataxia telangiectasia and rad3 related protein (ATR) inhibition and poly (ADP-ribose) polymerase (PARP) inhibition (CAiPi) is an effective approach to overcoming the intrinsic radiation resistance of GSC.
Materials and Methods

Derivation and maintenance of primary GBM cell lines
Primary GBM cell lines E2, G7, R10, R15, R24, R9, S2 were derived from resected tumors and maintained as described previously (12, 21) , approved by the local regional Ethics Committee (LREC ref 04/Q0108/60) in compliance with the UK Human Tissue Act 2004 (HTA License ref 12315). Tumorigenicity of paired GSC and differentiated GBM cell lines has been described previously (12, 21), (summarized in Supplemental table 1). Cell lines were utilized for 20 passages from thaw prior to being discarded and were tested for the presence of mycoplasma using the Lonza MycoAlert (LT07-318) assay on a 3 monthly basis.
Immunohistochemistry/immunofluorescence on tissue sections
Immunofluorescence microscopy on paraffin embedded sections was carried out as described previously (22). Following antigen retrieval sections were incubated sequentially with primary and secondary antibodies (Supplemental tables 2 and 3).
Immunofluorescence images were acquired as Z stacks with a Zeiss 780 confocal microscope and processed using maximum intensity projection (MIP) method where individual nuclei were selected and quantified for mean fluorescent intensity (MFI) values using ImageJ. Sox2 high and low values were characterized as being above and below the median Sox2 MFI value in the whole imaged cell population respectively with the MFI of RPA32 being compared between the two groups. A minimum of 150 (range 150-700) nuclei per sample were quantified from 6-12 63x magnification fields.
Non fluorescent immunohistochemistry slides were imaged using a Leica Slidepath system.
Clonogenic and neurosphere assays
Clonogenic survival assays were performed as described previously (12, 23 Cell cycle analysis using BrdU was carried out as described previously (12). Briefly, bulk and GSC were incubated with 10 µM BrdU for 35 minutes. Cells were washed in PBS and fixed in 70% ethanol. Samples were co-stained with anti-BrdU-FITC antibody (BD Bioscience) and propidium iodide. Flow cytometry data was collected using FACSVerse (BD Biosciences) following doublet discrimination and analyzed using FlowJo software (Tristar).
Cell viability was carried out using CellTiter-Glo® according to manufacturer's protocol (Promega). Briefly, bulk cells and GSC were plated out in 96 well plates and treated with Olaparib (1 µM) and VE821 (1, 3 or 5 µM) for 24 hours or 6 days, replaced with fresh media and cultured for a further 5 days followed by followed by detection of luminescence (Promega GLOMAX).
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In vitro immunofluorescence
Paired bulk and GSC were plated on coverslips coated with Matrigel. For BrdU studies, sub confluent paired bulk and/or GSCs were cultured on coverslips and pulse labelled with 10µM of BrdU for 30 minutes followed by fixation in 4% formaldehyde.
Immunofluorescent visualization of RPA and pATM s1981 required removal of nonchromatin bound nuclear protein using an extraction buffer (24) . Coverslips were washed in PBS and denatured in 2M HCl followed by immunostaining with anti-BrdU and γ-H2AX antibodies. For DDR inhibition studies, sub confluent cells were incubated with Olaparib and/or VE821 for 24 hours and fixed in 4% formaldehyde. Cells were incubated with anti-γ-H2AX, BrdU, RPA 32 and 53BP1 antibodies overnight at 
DNA fiber assays
DNA fiber assays were performed as described previously (15) . Briefly, cultured cells were incubated for 20 minutes with media containing CIdU (25µM) followed by PBS wash and incubation with media containing IdU (250µM). Cell suspensions were pipetted onto glass microscopy slides and lysed. Slides were raised to an angle of 30 0 in order to stretch DNA fibers along the slide. Immunostaining was then performed.
CIdU was detected using anti BrdU (rat) primary antibody (Abcam ab6326 1:400) and
anti-rat alexa fluorophore 555 (Invitrogen A21434 1:500) secondary. IdU was detected using anti BrdU (mouse) primary antibody (BD 347580 1:500) and anti-mouse alexa fluorophore 488 (Invitrogen A11017 1:500).
Drug treatment and radiation
ATR inhibitor VE821 (Vertex Pharmaceuticals) and PARP inhibitor olaparib (Selleckchem) were dissolved in DMSO and used at concentrations stated. A concentration of 5µM VE821 was found to be sufficient to inhibit phosphorylation of Chk1s345 following 5Gy radiation (Supplementary figure 1B ). An XStrahl RS225 cabinet at room temperature with 195 kV/15 mA X rays producing a dose rate of 1.6
Gy per minute was utilized for in vitro radiation studies. For UV studies, media was removed and cells were irradiated with 10 JM -2 UV (Stratalinker, Stratagene).
Western blotting
Western blotting was carried out as described previously (23).
RNA sequencing and bioinformatics
Total RNA was extracted from 7 paired bulk and GSC followed by generation of from the Bioconductor data analysis suite and differential gene expression analysis based on the negative binomial distribution using the DESeq package (28) .
Statistical Analyses
All experiments were repeated and data points reported as mean +/-SEM. Correlation of Sox2 and RPA32 integrated density was performed using Spearman ranks due to non-normal distribution of these variables. 
Results
Radioresistant GSC demonstrate up regulation of DNA replication stress response markers
We previously characterized constitutive DDR activation and associated 
Replicating GSC show altered cell cycle progression and increased replication stress in vitro
Cell cycle studies demonstrated significantly higher proportions of S phase cells in GSC than in tumor bulk populations (Figure 2A ), despite GSC cultures having similar proliferation rates to tumor bulk cultures as shown in previous work (12), indicating that GSC have a prolonged S phase duration. A likely explanation is that GSC have slower DNA replication velocity than tumor bulk populations because of elevated RS.
We confirmed elevated RS levels in GSC using the 'gold standard' DNA fiber assay Figure 2D ) in comparison to E2 bulk cultures (asymmetry defined as >33% difference in length between bidirectional elongating IdU fibers i.e. IdU1/IdU2 ≥ 1.33 (36) ). This effect was also observed in E2 CD133+ versus CD133-sorted cell populations ( Figure   2D ). Linear regression of long versus short track length showed significantly different gradient values for E2 GSC versus bulk cells and for E2 CD133+ versus CD133-cells ( Figure 2D ). Taken together our results show that RS in GSC is associated with reduced DNA replication velocity and higher rates of fork stalling. GSC identified by BrdU incorporation had significantly more 53BP1 nuclear foci than tumor bulk cells ( Figure 3A ). γ-H2AX foci were also more numerous in S phase GSC than tumor bulk cells ( Figure 3B ). Furthermore, in S phase GSC cultures, γ-H2AX foci co-localized with areas of intense BrdU staining, which represent concentrations of replication forks and their associated DNA replication machinery and have been described as 'replication factories' (37) . Co-localization of γ-H2AX and BrdU foci was significantly higher in GSC than tumor bulk cells ( Figure 3C ), confirming formation of DNA DSBs during aberrant DNA synthesis and providing a likely explanation for constitutive DDR activation in GSC.
GSC exhibit increased numbers of
To explore potential mechanisms responsible for elevated RS in GSC we analyzed changes in global gene expression profile between paired GSC and tumor bulk cells derived from 7 primary GBM cell lines using high throughput RNA sequencing. We first investigated if genes associated with DNA replication and/or the cellular response to RS were responsible for elevated RS in GSC. For this purpose, expression levels of genes encoding proteins known to be enriched on nascent DNA during unperturbed replication ('replication machinery' genes) and under conditions of RS induced by exposure to hydroxyurea ('HU stalled forks' genes) from previously published lists were examined in GSC and bulk cell populations (35) . Overall, no significant differences in expression of 'replication machinery' or 'HU stalled fork' genes were observed between GSC and tumor bulk cells (Supplementary figure S2B i,ii). Indeed only 2 of 82 transcribed 'replication machinery' genes and 4 of 131 transcribed 'HU stalled fork' genes showed greater than 2.5 fold differential expression between GSC and bulk cells. From these data we concluded that altered expression of genes associated with nascent DNA was unlikely to be responsible for elevated RS in GSC.
Given that aphidicolin could generate radiation resistance in our non-GSC primary GBM cultures ( Figure 1F) data revealed that 14 out of 73 VLGs (>850 Kbp in length) demonstrated a 2.5 fold or greater expression in GSC relative to tumor bulk cells ( Figure 3D ), and that 9 of these genes were significantly overexpressed compared to paired bulk populations across all 7 cell lines ( Figure 3D ). If VLGs are defined more stringently as being greater than 1 Mbp in length, the association remained significant: expression of 5 out of 31 genes >1 Mbp was > 2.5 fold greater in GSC than bulk cells, of which 3 were significantly overexpressed across all 7 cell lines ( Figure 3E ). These include: (20) . In addition, a further study has identified intragenic DNA origin firing in highly transcribed genes with consequent replication-transcription collisions as a mechanism for oncogenic RS (43) . Although much debated, neural progenitor cells have been proposed as a cell of origin for GBM (44) . Therefore the description of RS induced DNA DSB formation in transcriptionally active long neural genes in neural progenitor cells and the role of intragenic origins in generating oncogenic RS are highly relevant to our own data in GSC. We propose that replicationtranscription collisions due to active transcription of long neural genes in GSC is responsible for the elevated RS in GSC, resulting in generation of DNA DSBs, constitutive DDR activation and consequent therapeutic resistance.
GSC show enhanced replication stress in murine intracranial orthotopic xenografts and in human GBM tumor samples
Having observed compelling evidence of increased RS in GSC in vitro, we investigated whether this phenotype was also present in vivo. Dual immunofluorescent staining for Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer Research.
RPA32 and the putative GSC marker Sox2 was undertaken in sections of orthotopic xenograft tumors derived from CD133+ E2 GSC, which generate highly invasive, diffuse tumors and in tumors derived from G7 GSC which form a tumour mass with an invasive front typical of human GBM ( Figure 4A, B and Supplementary Figure S3A -E).
Our data showed a higher MFI of RPA32 staining in high (defined as greater than median) Sox2 expressing cells relative to low (less than median) Sox 2 expressing cells, consistent with the presence of elevated RS levels in the GSC subpopulation.
MFI values of Sox2 and RPA32 also showed a significant positive correlation ( Figure   4A To confirm the clinical relevance of these observations, dual immunofluorescence staining for Sox2 and RPA32 was performed in human tumor sections from four GBM patients ( Figure 4C and Supplementary figure S5A-D). Consistent with our earlier xenograft studies ( Figure 4A and 4B), MFI of RPA32 was significantly higher in cell populations which exhibited greater than median MFI of Sox2 ( Figure 4C ). This observation was reproduced using Olig2 as a GSC marker (Supplementary figure   S5D ). RPA32 and Sox2 expression also showed significant positive correlation in all tumors examined (Supplementary figure S5A-C) .
Inhibition of the RS response in GSC reduces neurosphere formation, generates DNA DSBs and abrogates radiation resistance
Our data indicate that constitutive RS represents a promising, GSC specific therapeutic target in GBM, which is a cancer of unmet need. To validate this concept we used olaparib, a small molecule inhibitor of poly (ADP-ribose) polymerase Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer Research.
(PARP) currently in clinical trials for GBM, and VE821, a potent and specific inhibitor of ATR (45) , to target key elements of the DDR and RS responses. PARP1 facilitates restart of stalled replication forks (46) while ATR has a key role in enabling cells to tolerate RS via activation of cell cycle checkpoints, inhibition of global origin firing and stabilization of stalled replication forks. Inhibition of ATR (5 μM VE821) significantly inhibited neurosphere formation in all three GSC populations tested whereas inhibition of PARP (1 μM olaparib) had little or no effect ( Figure 5A) . However, addition of olaparib to VE821, (Combined ATR inhibition and PARP inhibition; 'CAiPi') yielded significant, supra-additive inhibition of neurosphere formation, which is a fundamental property of GSC that requires proliferation and self-renewal. Since tumor bulk cultures do not form neurospheres, cell viability assays were undertaken to enable comparison of the effects of CAiPi on paired GSC and tumor bulk cultures. Consistent with our hypothesis that RS is an integral and targetable characteristic of GSC, these populations were significantly more sensitive to CAiPi than tumor bulk cells ( Figure   5B ). Addition of PARPi to GSC or bulk cultures did not affect DNA replication velocities at the clinically relevant concentrations examined, whereas addition of ATRi or CAiPi reduced replication velocities in both GSC and bulk ( Figure 5C ). Further mechanistic studies in E2 cells showed increased induction of γ-H2AX foci and micronuclei ( Figure   5C ) in GSC by CAiPi, supporting the concept that higher basal RS in GSC renders them particularly vulnerable to increased DNA damage and consequent cell death when subjected to inhibition of the DDR. Furthermore, and of profound clinical relevance, clonogenic survival assays revealed that CAiPi completely abrogated the radioresistance of GSC ( Figure 5D ), yielding sensitizer enhancement ratios at 37% survival of between 2 and 3.6. The radiosensitizing effect of the combination was significantly greater in GSC than in bulk cells when SER 0.37 values were compared ( Figure 5D ). Of note, R10 GSC were not radiosensitized by olaparib alone, however combined ATR and PARP inhibition resulted in potent radiosensitization. γ-H2AX foci analyses confirmed that CAiPi generates an excess of DNA DSBs in GSC in combination with radiation, (Figure 5D iv).
Discussion
Radiation resistance of GSC is a well-recognized yet poorly understood phenomenon, comprehension of which is vitally important to attempts to improve the therapeutic index of current therapy for GBM, since improvements in patient survival depend upon our ability to control or eradicate this tumor cell fraction. Despite characterization of up regulated DDR in cancer stem cells of different tumor types, the underlying reason for activated DDR and consequent radiation resistance in GSC has remained elusive.
Given the ubiquity of this phenotype in GSC and its prevalence in cancer stem cells of other tumor types, deeper understanding of the responsible mechanisms is predicted to generate highly appealing targets for clinical therapy.
RS has previously been implicated in the evolution of GBM and other cancers, particularly with regard to oncogene-induced senescence and as an anticancer barrier in early tumorigenesis (14, (47) (48) (49) . Indeed, a recent study has suggested reliance upon the BRCA1-RRM2 axis for protection from RS in GBM (50) . These studies validate that RS is a general feature of GBM, and may result in activated DDR in the tumor as a whole, however do not address whether RS is of particular importance in GSC, or the role of RS in determining DDR activation in GSC and have not shown that RS is responsible for radiation resistance. RS has recently been documented in nonmalignant embryonic stem cells, which display constitutively active DDR and prolonged S phase occupancy due to abnormal cell cycle progression. These features rapidly diminish upon differentiation (9) . Our data provide novel insights into the importance of RS in the GSC phenotype and direct evidence that RS is responsible for the activation of DDR and subsequent radiation resistance in GSC.
Furthermore, we identify replication transcription collisions as a result of increased expression of long neural genes as a likely mechanism for RS in GSC, an observation that correlates closely with recently published studies in neural progenitor cells which demonstrate that DSB arising from replication stress are preferentially located in long neural genes (20) . Indeed, several of these genes, namely DCC, CADM2 and PTPRT are significantly overexpressed across a panel of 7 GSC cultures. A further study of particular relevance to our data has recently described a novel mechanism for oncogenic RS dependent upon intragenic origin firing within highly transcribed genes (43) . Taken together these data support the controversial hypothesis that GSC derive from neural stem cells and provide grounds for further studies.
Finally we show that RS responses in GSC can be specifically targeted via dual inhibition of the key DDR and RS response proteins PARP and ATR. Our data demonstrate that GSC are significantly more sensitive to RS response targeting than non-GSC because of increased DNA DSB formation in GSC. Interestingly, GSC were also sensitized to radiation by dual ATR-PARP inhibition to a significantly greater degree than non-GSC, further validating our hypothesis that the radiation resistance of GSC is highly dependent on RS. Our results also suggest the feasibility of DDR targeting agents as promising therapies for GBM, both alone and in combination with radiotherapy.
Overall, our observations elucidate for the first time the mechanism underlying DDR activation and radioresistance in GSC, support a NSC origin for GSC and identify RS response as a GSC specific therapeutic target with the potential to improve patient outcomes from GBM. iii Quantification of radiation sensitizer enhancement ratios for 0.37 survival following combined ATRi/PARPi in E2 and R10 GSC and bulk (n≥3, mean +/-SEM). iv Quantification of median γ-H2AX foci per nucleus in E2 GSC and bulk cells following exposure to CAiPi or DMSO for 1 hour pre and 24 hours post irradiation with 2Gy or sham irradiation. (median +/-range, n = 1, *p<0.05, **p<0.01, Mann Whitney U test).
